Eli Lilly's strong GLP-1 drug demand and pipeline advances drive growth, while Western Digital and Vertiv ride AI-fueled momentum and market expansion.

Eli Lilly, Western Digital and Vertiv are drawing attention as AI demand, GLP-1 drugs and data center growth fuel momentum.

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug development.

The worldwide AI race is fast developing beyond the computer screen and focusing on the physical world around us. Top labs ...

President Trump is in Beijing for a state visit to America’s chief global competitor, and increasingly, its chief ...

PBS NC helps your community explore new worlds and ideas through programs that educate, inform and inspire. Your ...

As it adapts to the artificial intelligence era, the company is pushing many of its 78,000 workers to use the technology, and ...

The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.

When Mostafa Mubarak stepped up to the podium at the University of Kentucky's May 2026 Commencement Ceremony, he was one of ...

Isomorphic Labs, which hasn’t yet disclosed a molecule or reached the clinic, breaks the recent trend of investors putting ...

GLP-1 therapies created a consumer-driven market for pharmaceuticals that pairs digital access, partnerships, and retention ...

US President Donald Trump is likely to focus on trade and economic matters during his expected meeting with Chinese President ...